Boston Strategics Corporation

Boston Strategics Corporation Provides a New Model for Effective Drug Development for Patients. Together, we have redesigned the process of developing therapeutic drugs with the goal of delivering new therapies to patients faster, more efficiently, and at a lower overall cost. The pharmaceutical industry is facing a productivity crisis. In recent years, the cost of drug development has risen sharply, from just over $805 million per product in 2003 to nearly $2.6 billion in 2015. Existing development pipelines suffer from high overheads, sluggish corporate infrastructures, unfocused large project teams, and sometimes even a lack of specific expertise. Business decisions often do not prioritize patient needs. As a result, drug success rates are declining while development costs continue to rise.